Roy, M., Chandrakanth, M., Agarwala, V., Muddu, V. K., Chanana, R., Saha, R., Turkar, S. W., Sreenath, D. N. D., Sharma, A., Dasgupta, A., Sen, N., Mandal, K., Sardar, P. K., Sadhya, A., Manna, R., Rout, S., Momit, G., Kumar, S., Basu, M., Nayak, H. (2026). ADAPT-T-DXd: Multi-institutional real-world study of dose-adapted trastuzumab deruxtecan in HER2-positive and HER2-low metastatic breast cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1106